Bright Rock Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bright Rock Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.8M	Hold	27,500	–	–	2.76%	9
2026 Q1	$13.5M	Hold	27,500	–	–	2.67%	8
2025 Q4	$15.9M	Hold	27,500	–	–	3.13%	4
2025 Q3	$13.3M	Hold	27,500	–	–	2.61%	7
2025 Q2	$11.2M	Buy	27,500 +18,000	+189%	+$7.53M	2.26%	15
2025 Q1	$4.73M	Hold	9,500	–	–	1%	37
2024 Q4	$4.94M	Hold	9,500	–	–	1.05%	34
2024 Q3	$5.88M	Hold	9,500	–	–	1.18%	34
2024 Q2	$5.25M	Hold	9,500	–	–	1.11%	33
2024 Q1	$5.52M	Hold	9,500	–	–	1.14%	32
2023 Q4	$5.04M	Hold	9,500	–	–	1.14%	31
2023 Q3	$4.81M	Hold	9,500	–	–	1.17%	31
2023 Q2	$4.96M	Hold	9,500	–	–	1.16%	32
2023 Q1	$5.48M	Hold	9,500	–	–	1.37%	27
2022 Q4	$5.23M	Hold	9,500	–	–	1.36%	29
2022 Q3	$4.82M	Hold	9,500	–	–	1.35%	31
2022 Q2	$5.16M	Hold	9,500	–	–	1.39%	29
2022 Q1	$5.61M	Hold	9,500	–	–	1.32%	31
2021 Q4	$6.34M	Hold	9,500	–	–	1.44%	29
2021 Q3	$5.43M	Hold	9,500	–	–	1.36%	30
2021 Q2	$4.79M	Hold	9,500	–	–	1.15%	38
2021 Q1	$4.34M	Hold	9,500	–	–	1.11%	39
2020 Q4	$4.42M	Hold	9,500	–	–	1.21%	39
2020 Q3	$4.19M	Hold	9,500	–	–	1.24%	37
2020 Q2	$3.44M	Sell	9,500 -1,500	-14%	-$503K	1.08%	40
2020 Q1	$3.12M	Hold	11,000	–	–	1.14%	39
2019 Q4	$3.57M	Sell	11,000 -10,000	-48%	-$3.03M	1.05%	39
2019 Q3	$5.94M	Hold	21,000	–	–	1.86%	20
2019 Q2	$6.17M	Sell	21,000 -5,000	-19%	-$1.38M	1.97%	19
2019 Q1	$7.12M	Hold	26,000	–	–	2.38%	11
2018 Q4	$5.82M	Sell	26,000 -13,000	-33%	-$3.05M	2.19%	17
2018 Q3	$9.52M	Hold	39,000	–	–	3.11%	3
2018 Q2	$8.08M	Hold	39,000	–	–	2.77%	7
2018 Q1	$8.05M	Hold	39,000	–	–	2.77%	6
2017 Q4	$7.41M	Hold	39,000	–	–	2.01%	10
2017 Q3	$7.38M	Sell	39,000 -3,000	-7%	-$543K	2.14%	11
2017 Q2	$7.33M	Buy	42,000 +28,000	+200%	+$4.7M	2.16%	10
2017 Q1	$2.15M	Hold	14,000	–	–	0.64%	56
2016 Q4	$1.98M	Hold	14,000	–	–	0.61%	55
2016 Q3	$2.23M	Sell	14,000 -40	-0.3%	-$6.16K	0.71%	52
2016 Q2	$2.08M	Hold	14,040	–	–	0.67%	55
2016 Q1	$1.99M	Buy	14,040 +40	+0.3%	+$5.36K	0.68%	53
2015 Q4	$1.99M	Hold	14,000	–	–	0.74%	49
2015 Q3	$1.71M	Hold	14,000	–	–	0.69%	52
2015 Q2	$1.82M	Buy	+14,000	New	+$1.83M	0.68%	51

Other funds holding TMO

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Bright Rock Capital Management's TMO Position: Q2 2026 in Review

Bright Rock Capital Management held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 27,500 shares worth $13.8M. The position accounts for 2.76% of the portfolio, ranked #9.

Bright Rock Capital Management first reported a position in TMO in Q2 2015 and has held it in 45 quarters since. The position peaked at $15.9M in Q4 2025. 637 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Bright Rock Capital Management held 27,500 shares of Thermo Fisher Scientific worth $13.8M as of Q2 2026.
Bright Rock Capital Management left its Thermo Fisher Scientific share count unchanged in Q2 2026.
Thermo Fisher Scientific made up 2.76% of Bright Rock Capital Management's portfolio in Q2 2026, its #9 holding.
Bright Rock Capital Management first reported a position in Thermo Fisher Scientific in Q2 2015 and has held it in 45 quarters since.
Bright Rock Capital Management's Thermo Fisher Scientific position peaked at $15.9M in Q4 2025.
637 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Bright Rock Capital Management's 13F filing for Q2 2026, filed 8 Jul 2026.